A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML. [electronic resource]
Producer: 20190403Description: 1680-1684 p. digitalISSN:- 2473-9537
- Aniline Compounds -- adverse effects
- Human Umbilical Vein Endothelial Cells -- metabolism
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Nitriles -- adverse effects
- Phosphoproteins -- metabolism
- Protein Kinase Inhibitors -- adverse effects
- Proteomics
- Quinolines -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.